Budapest, Hungary

Peter Huszthy

This inventor holds 1 USPTO granted patent. Top assignee: Egis Gyogyszergyar. Active years: 1987.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter Huszthy. Retrieved from https://idiyas.com/inventor/peter-huszthy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 16.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1987

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Peter Huszthy

Introduction

Peter Huszthy, an inventive spirit from Budapest, Hungary, has made his mark in the field of pharmaceuticals. With a focus on unique chemical compounds, Huszthy’s work exemplifies the intersection of science and innovation.

Latest Patents

Huszthy holds a patent for his invention titled "Iminothiazolidine derivatives." This invention pertains to novel iminothiazolidine derivatives represented by a specific chemical formula. The unique properties of these compounds open up new avenues for research and application in various fields, particularly in pharmaceuticals.

Career Highlights

Currently, Peter Huszthy is associated with Egis Gyógyszergyár, a prominent pharmaceutical company in Hungary. His expertise in chemistry and innovative approach to drug development has contributed significantly to the company's research initiatives.

Collaborations

Throughout his career, Huszthy has collaborated with esteemed colleagues, including Karoly Lempert and Gyula Hornyak. Together, they have shared insights and knowledge, driving forward the innovations that have potential therapeutic applications.

Conclusion

Peter Huszthy’s contributions to the field of pharmaceuticals reflect not only his ingenuity as an inventor but also the collaborative spirit of scientific research. His work with iminothiazolidine derivatives marks a significant step in the development of new therapeutic agents, showcasing the importance of innovation in enhancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…